Double-blind comparison of cephradine and cephalexin in the treatment of skin and soft-tissue infections due to Staphylococcus aureus.
D000328:Adult; D002506:Cephalexin / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D002510:Cephalosporinase / Q000378:metabolism; D002511:Cephalosporins / Q000627:therapeutic use*; D002515:Cephradine / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D006801:Humans; D006868:Hydrolysis; D008826:Microbial Sensitivity Tests; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000201:enzymology; D013211:Staphylococcus aureus / Q000187:drug effects
D002511:Cephalosporins; D002510:Cephalosporinase; D002515:Cephradine; D002506:Cephalexin